Table 1. Demographics and clinical assessment scores for the RA, OA, SLE patients and healthy controls.
| S.N. | Characterstics | RA (n = 60) | OA (n = 34) | SLE (n = 10) | Healthy Control (n = 60) | |
| Non severe RA (n = 22) | Severe RA (n = 38) | |||||
| 1 | Mean AGE ± SD | 25±11 | 49±10 | 67±8 | 34±4 | 35±10 |
| 2 | Mean weight±SD | 54±10 | 55±10 | 60 ±15 | 40±10 | 55±5 |
| 3 | SEX | 16F+6M | 32F+6M | 26F+8M | 10F | 30F+30M |
| 4 | Mean Disease Duration(Y) | 3±1 | 10±5 | 8±5 | 7±5 | - |
| 5 | Mean Serum CRP (mg/liter) ± SD | 35±5 | 80±5 | 30±2 | 15±1 | 10±5 |
| 6 | Mean Tender joint | 2±1 | 10±5 | 3 ± 2 | 3±1 | - |
| 7 | Mean Swollen joints±SD | 2±1 | 10±5 | 3±2 | 2±1 | - |
| 8 | RF (IU/ml) | 30±10 | 80±20 | 25±5 | 20±5 | 15±5 |
| 9 | Mean ESR (mm/hr) | 20±5 | 85±20 | 45±5 | 40±5 | 10±5 |
| 10 | DAS 28 score±SD | 3±2 | 6.5±2 | - | - | - |
| 11 | Medicines | Mtx, HCQS, Tcz, Aba, Anti TNF-Etn, Anti TNF- Ifx | Mtx, HCQS, Tcz, Aba, Anti TNF-Etn, Anti TNF- Ifx | NSAIDs | HCQC, Prednisone, Azathiprine, Cyclophospha- mide | - |
RA – Rheumatoid Arthritis, OA – Osteoarthritis, SLE – Systemic lupus erythematosus, SD – Standard Deviation, RF – Rheumatoid Factor, ESR – Erythrocyte Sedimentation Rate, CRP – C Reactive Protein, IU – International Unit, ml – Milliliter, mm – Millimeter, hr – Hour, DAS 28 – Disease Activity Score (maximum 28 joints), F – Female, M-Male, NSAIDs - Nonsteroidal anti-inflammatory drugs. Mtx-Methotrexate, HCQS -Hydroxychloroquine,TCZ- tocilizumab, Aba- Abatacepr, Etn-Etanercept, Ifx- Infliximab.